Our Team

Partner & VP Venture Operations
Jennifer Carter
Jennifer Carter Lehot

Jennifer brings over 20 years of experience from various roles across the McKesson enterprise ranging from marketing, business development, strategy and sales operations. In addition to investing and supporting health technology and services companies, Jennifer oversees operations for the team which includes talent, budget and portfolio development. 

Jennifer holds a B.S. in Economics from Boston College.  Although born and raised in San Francisco, Jennifer spends harvest season on the family farm cultivating pluots and disrupting the plum and apricot industries.

Investment Associate
Arjun Chirumamilla
Arjun Chirumamilla

Arjun is an associate on the investment team responsible for evaluating new investment opportunities. Before joining the McKesson Ventures team, he started out his career doing investment banking at Moelis & Company, working on M&A and restructuring transactions across the spectrum of healthcare. 

Sr Director, Portfolio Development
Lizzie Lee
Lizzie Lee

Lizzie brings a decade of healthcare industry experience to her work in portfolio development. She’s an advocate for the power of what novel startups and industry veterans can achieve together. In her prior role on McKesson’s enterprise strategy team, Lizzie helped launch and manage a multi-year strategic growth initiative to position the business through long-term market disruption.

Prior to this, Lizzie was a consultant at ZS Associates where she worked with top pharmaceutical companies on go-to-market strategy, launch planning and market access. She also helped build the firm’s innovation team. Lizzie earned her B.S. in Mechanical Engineering at Northwestern University. Although she lives and breathes the healthcare industry, she has a sweet tooth that she satisfies with help from her family’s popcorn business in Virginia.

SVP and Managing Director
Dave Schulte
Dave Schultz

Dave has been investing in healthcare technology and services businesses for nearly two decades.  He leads McKesson Ventures (MV) and previously led Kaiser Permanente Ventures. His MV investments include: Aledade, AllyAlign Health (recapitalized by NEA), Clinical Ink, IVX Health, Komodo Health, Landmark Health (acquired by Optum), Lightship, M2Gen, Oncology Analytics and SHYFT Analytics (acquired by Medidata). 

Dave is a member of the Harvard Kennedy School Health Policy Leadership Council, the Boehringer Ingelheim Digital Health Advisory Council and the St. John’s University Private Investment Fund. He is a graduate of St. John’s University and earned a Master of Public Policy from the Harvard Kennedy School.

Partner
Michelle Snyder
Michelle Snyder

Michelle Snyder brings over 25 years’ healthcare industry experience in marketing, business development, strategic planning, and general management, and is recognized as a leader in the digital health space. Prior to joining McKesson Ventures, she was Chief Marketing Officer at Welltok as well as an early executive at Epocrates, where she worked for over a decade to build the company into one of the most recognized brands among clinicians. Her MV investments include Galileo, Reimagine Care, and RxVantage.

Michelle has also served as an Executive-in-Residence at InterWest Partners, investing in digital health companies and advising portfolio companies. In addition, she has held consulting and policy positions at The Wilkerson Group, the Lewin Group and the Georgetown Center for Health Policy Studies.

Michelle earned her M.B.A. at the Kellogg School of Management at Northwestern University and her B.A. from Carleton College. Though she’s been in the Bay Area for over 20 years, she still dons green and gold and wears her Cheesehead proudly on Sundays.

Partner
Carrie Hurwitz Williams
Carrie Hurwitz Williams, Principal at McKesson Ventures

Carrie brings over 15 years of healthcare experience from several vantage points within the healthcare industry. Prior to joining McKesson Ventures, she served as Vice President, Strategy and Business Development for Omada Health, where she focused heavily on all elements of commercial strategy and partnerships. Her MV investments include Evidation Health, Koneksa Health, Lambert Vet Supply, Xealth, AllStripes, Tact.ai, and Propeller Health (acquired by ResMed).

Williams holds a MBA from the Haas School of Business at the University of California at Berkeley and a BS in biology from the University of Massachusetts Amherst.  After more than a dozen years in the Bay Area, she is now back in the Boston area, where she lives with her husband, daughters, and their golden retriever, Fenway.  A piece of her heart will always be in San Francisco, so maybe it’s time to rename the dog “Oracle.”

Guide Dog & Office Puppy
McKesson
GDB Puppy McKesson - cropped

McKesson is one of the newest recruits for Guide Dogs for the Blind. He is a yellow male Labrador retriever, born on March 10, 2017. He just left campus a week ago to spend the next year with his puppy raisers in Snohomish, Washington. He was named in honor of McKesson Ventures’ recent donation to GDB. Photo credit: Guide Dogs for the Blind.  

 

McKesson EVP, Chief Strategy Officer
Tom Rodgers
Tom Rodgers

In 2014, Tom founded McKesson Ventures and built the program before moving into his current role as EVP and Chief Strategy Officer for McKesson in 2020. During his tenure at McKesson Ventures, Tom led investments in Accolade (ACCD), Aetion, Carena / Amwell (AMWL), ClearCare, Grail, Hims, and Pharmapacks, to name a few. Tom continues to oversee the program and the investment committee.